Chemoinformaics analysis of Aristola-1(10),8-Dien-2-One
| Molecular Weight | 216.324 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 14 |
| Exact Molecular Weight | 216.151 | nRing | 3 |
| Solubility: LogS | -4.724 | nHRing | 0 |
| Solubility: LogP | 3.03 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 39.1879 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.606 |
| Synth | 4.567 |
| Natural Product Likeliness | 3.063 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.996 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.74 |
| MDCK | 0.0000344 |
| BBB | 0.327 |
| PPB | 0.903148 |
| VDSS | 0.858 |
| FU | 0.067002 |
| CYP1A2-inh | 0.069 |
| CYP1A2-sub | 0.444 |
| CYP2c19-inh | 0.631 |
| CYP2c19-sub | 0.923 |
| CYP2c9-inh | 0.334 |
| CYP2c9-sub | 0.276 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.524 |
| CYP3a4-inh | 0.221 |
| CYP3a4-sub | 0.612 |
| CL | 17.77 |
| T12 | 0.14 |
| hERG | 0.018 |
| Ames | 0.006 |
| ROA | 0.561 |
| SkinSen | 0.921 |
| Carcinogencity | 0.668 |
| EI | 0.018 |
| Respiratory | 0.96 |
| NR-Aromatase | 0.048 |
| Antiviral | Yes |
| Prediction | 0.819264 |